SCHEMBL19904729

SCHEMBL19904729

CCCCOP(=O)(OCCCC)Oc1cccc(N)c1

nearest known ligand 0.72

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.55
CYP3A4 P08684 2/20 0.46
TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7768583 0.89 CYP3A4 (0.53) CYP3A4
SCHEMBL25284051 0.84 CYP3A4 (0.47) CYP3A4
SCHEMBL19904733 0.83 CYP3A4 (0.53) TSHRCYP3A4
SCHEMBL27042296 0.82 KMT2A (0.50) CYP3A4
SCHEMBL3234331 0.82 CYP3A4 (0.46) CYP3A4
SCHEMBL3229774 0.82 CYP3A4 (0.46) CYP3A4
SCHEMBL124571 0.81 CYP3A4 (0.55) CYP3A4
SCHEMBL31169485 0.81 CYP3A4 (0.47) CYP3A4
SCHEMBL16023560 0.80 KMT2A (0.58)
Triphenyl Phosphate SCHEMBL7526391 0.80 CYP3A4 (0.53) CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097428-B1 BUTYRYLCHOLINESTERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES MGP BIOTECHNOLOGIES INC (US) 2018-02-28 EP disclosed